Bone is the most common metastatic lesion in prostate cancer patient, while transforming growth factor β (TGF-β) signaling is identified to affect the metastatic tumor cell proliferation and osteolytic bone metastasis in several cancer types [10]. The gene discussed is TGFB1; the disease is cancer.